Leishmaniasis - 69 Studies Found
| Not yet recruiting |
: Single Dose Liposomal Amphotericin B for Visceral Leishmaniasis : Visceral Leishmaniasis : 2012-03-27 : Drug: AMBISOME SINGLE DOSE AMBISOME FOR TREATMENT OF VISCERAL LEISHMANIASIS |
| Terminated |
: Efficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in Brazil : Visceral Leishmaniasis : 2011-03-07 :
|
| Terminated |
: Safety and Efficacy of Azithromycin to Treat Cutaneous Leishmaniasis : Cutaneous Leishmaniasis : 2008-05-20 :
|
| Completed |
: Miltefosine to Treat Cutaneous Leishmaniasis in Bolivia : Cutaneous Leishmaniasis : 2005-09-28 :
|
| Recruiting |
: Treatment of Leishmaniasis With Impavido® (Miltefosine): Higher-Weight Patient Registry : Leishmaniasis : 2015-04-22 : Drug: Miltefosine miltefosine: target 2.5 mg/kg/day for 28 days |
| Available |
: Paromomycin for Individuals With Uncomplicated Cutaneous Leishmaniasis : Leishmaniasis, Cutaneous : 2012-06-18 : Drug: Paromomycin Paromomycin Topical Cream applied to all lesions once a day for 20 days |
| Completed |
: Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Cutaneous Leishmaniasis : Leishmaniasis, Cutaneous : 2005-05-23 : Biological: Leish-111f + MPL-SE vaccine |
| Terminated |
: Safety, Efficacy, and PK of Topical Paromomycin/Gentamicin Cream for Treatment of Cutaneous Leishmaniasis : Leishmaniasis, Cutaneous : 2010-06-07 : Drug: WR 279,396 Topical application of WR 279,396 cream (15% paromomycin + 0.5% gentamicin)once daily f |
| Completed |
: Safety, Efficacy and Pharmacokinetics (PK) Study of WR 279,396 Versus Paromomycin for Treatment of Cutaneous Leishmaniasis (Peru-PK) : Leishmaniasis, Cutaneous : 2009-12-14 :
|
| Completed |
: Pharmacokinetics, Safety, and Efficacy Trial of WR 279,396 (Paromomycin + Gentamicin Topical Cream) and Paromomycin Topical Cream for the Treatment of Cutaneous Leishmaniasis in Panama : Leishmaniasis, Cutaneous : 2010-03-08 :
|